OC
Oppenheimer & Co Portfolio holdings
AUM
$7.56B
1-Year Return
24.19%
This Quarter Return
+24.39%
1 Year Return
+24.19%
3 Year Return
+89.94%
5 Year Return
+158.67%
10 Year Return
+361.14%
AUM
$3.87B
AUM Growth
+$571M
(+17%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
18.79%
Holding
1,345
New
153
Increased
459
Reduced
571
Closed
93
Top Buys
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$23.8M |
| 2 |
Microsoft
MSFT
|
$20.2M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$12.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$7.91M |
| 5 |
Salesforce
CRM
|
$7.02M |
Sector Composition
| 1 | Technology | 18.06% |
| 2 | Healthcare | 12.66% |
| 3 | Financials | 10.14% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
L3Harris
LHX
$51B
| $6.32M | 0.16% |
37,260
-8,356
| -18% | -$1.42M |
|
127
Chemed
CHE
$6.79B
| $6.23M | 0.16% |
13,809
-4,434
| -24% | -$2M |
|
128
iShares Russell 1000 Growth ETF
IWF
$117B
| $6.17M | 0.16% |
32,148
+1,913
| +6% | +$367K |
|
129
Zscaler
ZS
$42.7B
| $6.17M | 0.16% |
56,350
-10,783
| -16% | -$1.18M |
|
|
XLNX
130
DELISTED
Xilinx Inc
XLNX
| $6.15M | 0.16% |
62,479
+50
| +0.1% | +$4.92K |
|
131
Philip Morris
PM
$251B
| $6.08M | 0.16% |
86,734
-239
| -0.3% | -$16.7K |
|
132
CME Group
CME
$94.4B
| $6.02M | 0.16% |
37,011
-1,637
| -4% | -$266K |
|
133
Nike
NKE
$109B
| $6M | 0.16% |
61,181
-4,678
| -7% | -$459K |
|
134
Veeva Systems
VEEV
$44.7B
| $5.88M | 0.15% |
25,063
+15,233
| +155% | +$3.57M |
|
135
Xylem
XYL
$34.2B
| $5.87M | 0.15% |
90,326
-10,405
| -10% | -$676K |
|
136
Northrop Grumman
NOC
$83.2B
| $5.86M | 0.15% |
19,065
+235
| +1% | +$72.3K |
|
137
Automatic Data Processing
ADP
$120B
| $5.85M | 0.15% |
39,272
-218
| -0.6% | -$32.5K |
|
138
ProShares Short Russell2000
RWM
$123M
| $5.84M | 0.15% |
161,431
+147,961
| +1,098% | +$5.35M |
|
139
Public Service Enterprise Group
PEG
$40.5B
| $5.83M | 0.15% |
118,658
-4,522
| -4% | -$222K |
|
140
Brookfield
BN
$99.5B
| $5.77M | 0.15% |
218,455
+6,249
| +3% | +$165K |
|
141
Stryker
SYK
$150B
| $5.77M | 0.15% |
32,014
-9,185
| -22% | -$1.65M |
|
142
Humana
HUM
$37B
| $5.75M | 0.15% |
14,819
+168
| +1% | +$65.1K |
|
143
iShares MSCI Emerging Markets ETF
EEM
$19.2B
| $5.74M | 0.15% |
143,469
-15,202
| -10% | -$608K |
|
144
Invesco Ultra Short Duration ETF
GSY
$2.95B
| $5.73M | 0.15% |
113,537
+24,447
| +27% | +$1.23M |
|
145
SPDR S&P Biotech ETF
XBI
$5.39B
| $5.71M | 0.15% |
51,019
+10,883
| +27% | +$1.22M |
|
146
Charles Schwab
SCHW
$167B
| $5.67M | 0.15% |
168,096
+2,957
| +2% | +$99.8K |
|
147
TJX Companies
TJX
$155B
| $5.66M | 0.15% |
111,974
-11,836
| -10% | -$598K |
|
148
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $5.66M | 0.15% |
103,362
-4,950
| -5% | -$271K |
|
149
T Rowe Price
TROW
$23.8B
| $5.62M | 0.15% |
45,531
-226
| -0.5% | -$27.9K |
|
150
Air Products & Chemicals
APD
$64.5B
| $5.62M | 0.15% |
23,256
-2,768
| -11% | -$668K |
|